Lupin plans expansion, eyes Europe growth via acquisitions and launches

The pharma major acquired a portfolio of central nervous drug system drugs, including NaMuscla, through its acquisition of German drug maker Temmler Pharma in 2015

from Today's Paper http://bit.ly/2Su8WxM